The Risk Factors for Depression in Cancer Patients Undergoing Chemotherapy: a Systematic Review

Overview

Journal Support Care Cancer

Specialties Critical Care
Oncology

Date 2018 Sep 19

PMID 30225571

Citations 26

Authors

Shuangshuang Wen

Huimin Xiao

Yanqing Yang

Affiliations

Soon will be listed here.

Abstract

Purpose: This systematic review aims to identify the risk factors for depression in cancer patients undergoing chemotherapy.

Methods: Eight electronic databases were searched from inception of the databases established until August 2017. References for the included studies were retrieved by manual searching. The quality of the eligible studies was appraised by two persons using the 11-item checklist of the Agency for Healthcare Research and Quality (AHRQ).

Results: Among 5988 potentially relevant articles, 43 studies were eligible, with 17 studies of high quality and 25 studies of moderate quality. A total of 65 factors were extracted, including sociodemographic characteristics (n = 20), physiological condition (n = 20), disease and treatment (n = 12), and psychosocial factors (n = 13). Only social support, anxiety, perceived stress, and self-efficacy were found to be consistently associated with depression in cancer patients. There is not enough evidence to support the link between the other 61 factors and depression in cancer patients undergoing chemotherapy.

Conclusions: This review suggests that the development of depression programs should take social support, anxiety, perceived stress, and self-efficacy into account. More original studies with rigorous design are necessary to further confirm those 61 inconclusive risk factors for depression in cancer patients receiving chemotherapy.

Citing Articles

Prevalence and determinants of depression and its association with social support among cancer patients: implications for enhancing oncology care.

Alkubati S, Halboup A, Zoromba M, El-Gazar H, Pasay-An E, Salameh B BMC Psychol. 2025; 13(1):232.

PMID: 40069840 PMC: 11900610. DOI: 10.1186/s40359-025-02584-5.

Impact of assessing the emotional health status in the management of cancer patients.

Policiuc L, Bica C, Gulei D, Leucuta D, Berindan-Neagoe I Med Pharm Rep. 2024; 97(3):308-312.

PMID: 39234450 PMC: 11370854. DOI: 10.15386/mpr-2770.

Sleep, anxiety, depression, and stress in critically ill patients: a descriptive study in a Portuguese intensive care unit.

Silva R, Teixeira A, Pinho J, Marcos P, Santos J Acute Crit Care. 2024; 39(2):312-320.

PMID: 38863362 PMC: 11167415. DOI: 10.4266/acc.2023.01256.

Factors associated with depressive symptoms among cancer patients: a nationwide cross-sectional study.

Chen X, Ye C, Liu L, Li X BMC Public Health. 2024; 24(1):1443.

PMID: 38811910 PMC: 11137935. DOI: 10.1186/s12889-024-18898-9.

Psychological outcomes in patients with rare cancers: a systematic review and meta-analysis.

Low C, Loke S, Pang G, Sim B, Yang V EClinicalMedicine. 2024; 72:102631.

PMID: 38726223 PMC: 11079476. DOI: 10.1016/j.eclinm.2024.102631.

References

Blank T, Bellizzi K . A gerontologic perspective on cancer and aging. Cancer. 2008; 112(11 Suppl):2569-76. DOI: 10.1002/cncr.23444. View

Bandura A . Self-efficacy: toward a unifying theory of behavioral change. Psychol Rev. 1977; 84(2):191-215. DOI: 10.1037//0033-295x.84.2.191. View

Fagundes C, Jones D, Vichaya E, Lu C, Cleeland C . Socioeconomic status is associated with depressive severity among patients with advanced non-small-cell lung cancer: treatment setting and minority status do not make a difference. J Thorac Oncol. 2014; 9(10):1459-63. PMC: 4514021. DOI: 10.1097/JTO.0000000000000284. View

Chen S, Chang C, Chen K, Liu C . Association between depressive disorders and risk of breast cancer recurrence after curative surgery. Medicine (Baltimore). 2016; 95(33):e4547. PMC: 5370804. DOI: 10.1097/MD.0000000000004547. View

Alpert J, Fava M . Nutrition and depression: the role of folate. Nutr Rev. 1997; 55(5):145-9. DOI: 10.1111/j.1753-4887.1997.tb06468.x. View

Jacobson N, Newman M . Avoidance mediates the relationship between anxiety and depression over a decade later. J Anxiety Disord. 2014; 28(5):437-45. PMC: 4957550. DOI: 10.1016/j.janxdis.2014.03.007. View

von Gruenigen V, Hutchins J, Reidy A, Gibbons H, Daly B, Eldermire E . Gynecologic oncology patients' satisfaction and symptom severity during palliative chemotherapy. Health Qual Life Outcomes. 2006; 4:84. PMC: 1634850. DOI: 10.1186/1477-7525-4-84. View

Pandey M, Sarita G, Devi N, Thomas B, Hussain B, Krishnan R . Distress, anxiety, and depression in cancer patients undergoing chemotherapy. World J Surg Oncol. 2006; 4:68. PMC: 1592486. DOI: 10.1186/1477-7819-4-68. View

Bergerot C, Clark K, Nonino A, Waliany S, Buso M, Loscalzo M . Course of distress, anxiety, and depression in hematological cancer patients: Association between gender and grade of neoplasm. Palliat Support Care. 2013; 13(2):115-23. DOI: 10.1017/S1478951513000849. View

10.

Brandao T, Schulz M, Matos P . Psychological adjustment after breast cancer: a systematic review of longitudinal studies. Psychooncology. 2016; 26(7):917-926. DOI: 10.1002/pon.4230. View

11.

Cho H, Savitz J, Dantzer R, Teague T, Drevets W, Irwin M . Sleep disturbance and kynurenine metabolism in depression. J Psychosom Res. 2017; 99:1-7. PMC: 5526094. DOI: 10.1016/j.jpsychores.2017.05.016. View

12.

Farrell C, Brearley S, Pilling M, Molassiotis A . The impact of chemotherapy-related nausea on patients' nutritional status, psychological distress and quality of life. Support Care Cancer. 2012; 21(1):59-66. DOI: 10.1007/s00520-012-1493-9. View

13.

Bower J, Ganz P, Irwin M, Kwan L, Breen E, Cole S . Inflammation and behavioral symptoms after breast cancer treatment: do fatigue, depression, and sleep disturbance share a common underlying mechanism?. J Clin Oncol. 2011; 29(26):3517-22. PMC: 3179252. DOI: 10.1200/JCO.2011.36.1154. View

14.

Mielcarek P, Nowicka-Sauer K, Kozaka J . Anxiety and depression in patients with advanced ovarian cancer: a prospective study. J Psychosom Obstet Gynaecol. 2016; 37(2):57-67. DOI: 10.3109/0167482X.2016.1141891. View

15.

Saini A, Berruti A, Ferini-Strambi L, Castronovo V, Rametti E, Giuliano P . Restless legs syndrome as a cause of sleep disturbances in cancer patients receiving chemotherapy. J Pain Symptom Manage. 2012; 46(1):56-64. DOI: 10.1016/j.jpainsymman.2012.06.018. View

16.

Jehn C, Becker B, Flath B, Nogai H, Vuong L, Schmid P . Neurocognitive function, brain-derived neurotrophic factor (BDNF) and IL-6 levels in cancer patients with depression. J Neuroimmunol. 2015; 287:88-92. DOI: 10.1016/j.jneuroim.2015.08.012. View

17.

Chang-Quan H, Zheng-Rong W, Yong-Hong L, Yi-Zhou X, Qing-Xiu L . Education and risk for late life depression: a meta-analysis of published literature. Int J Psychiatry Med. 2010; 40(1):109-24. DOI: 10.2190/PM.40.1.i. View

18.

Saevarsdottir T, Fridriksdottir N, Gunnarsdottir S . Quality of life and symptoms of anxiety and depression of patients receiving cancer chemotherapy: longitudinal study. Cancer Nurs. 2009; 33(1):E1-E10. DOI: 10.1097/NCC.0b013e3181b4adb5. View

19.

Phillips R . Nutrition and depression in the community-based oldest-old. Home Healthc Nurse. 2012; 30(8):462-71. DOI: 10.1097/NHH.0b013e31826517ad. View

20.

Mitchell A, Chan M, Bhatti H, Halton M, Grassi L, Johansen C . Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol. 2011; 12(2):160-74. DOI: 10.1016/S1470-2045(11)70002-X. View